rs1010665693

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001018109.3(PIR):​c.616G>A​(p.Asp206Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000218 in 1,193,273 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.000021 ( 0 hom. 6 hem. )

Consequence

PIR
NM_001018109.3 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.91

Publications

0 publications found
Variant links:
Genes affected
PIR (HGNC:30048): (pirin) This gene encodes a member of the cupin superfamily. The encoded protein is an Fe(II)-containing nuclear protein expressed in all tissues of the body and concentrated within dot-like subnuclear structures. Interactions with nuclear factor I/CCAAT box transcription factor as well as B cell lymphoma 3-encoded oncoprotein suggest the encoded protein may act as a transcriptional cofactor and be involved in the regulation of DNA transcription and replication. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
PIR Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15517664).
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIRNM_001018109.3 linkc.616G>A p.Asp206Asn missense_variant Exon 8 of 10 ENST00000380420.10 NP_001018119.1 O00625A0A024RBX6
PIRNM_003662.4 linkc.616G>A p.Asp206Asn missense_variant Exon 8 of 10 NP_003653.1 O00625A0A024RBX6
PIR-FIGFNR_037859.2 linkn.921G>A non_coding_transcript_exon_variant Exon 8 of 15

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIRENST00000380420.10 linkc.616G>A p.Asp206Asn missense_variant Exon 8 of 10 1 NM_001018109.3 ENSP00000369785.5 O00625
PIRENST00000380421.3 linkc.616G>A p.Asp206Asn missense_variant Exon 8 of 10 1 ENSP00000369786.3 O00625
PIRENST00000484433.1 linkn.51G>A non_coding_transcript_exon_variant Exon 2 of 3 3
PIRENST00000492432.5 linkn.154G>A non_coding_transcript_exon_variant Exon 2 of 4 2

Frequencies

GnomAD3 genomes
AF:
0.0000268
AC:
3
AN:
112010
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000219
AC:
4
AN:
182950
AF XY:
0.0000445
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000213
AC:
23
AN:
1081263
Hom.:
0
Cov.:
27
AF XY:
0.0000173
AC XY:
6
AN XY:
347515
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26118
American (AMR)
AF:
0.00
AC:
0
AN:
35168
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19284
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30106
South Asian (SAS)
AF:
0.0000746
AC:
4
AN:
53648
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40513
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4084
European-Non Finnish (NFE)
AF:
0.0000230
AC:
19
AN:
826855
Other (OTH)
AF:
0.00
AC:
0
AN:
45487
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000268
AC:
3
AN:
112010
Hom.:
0
Cov.:
24
AF XY:
0.0000585
AC XY:
2
AN XY:
34172
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
30839
American (AMR)
AF:
0.00
AC:
0
AN:
10585
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3596
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2694
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6038
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000564
AC:
3
AN:
53159
Other (OTH)
AF:
0.00
AC:
0
AN:
1519
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000189
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000594

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 16, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.616G>A (p.D206N) alteration is located in exon 8 (coding exon 7) of the PIR gene. This alteration results from a G to A substitution at nucleotide position 616, causing the aspartic acid (D) at amino acid position 206 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
18
DANN
Benign
0.90
DEOGEN2
Benign
0.033
T;T
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.80
.;T
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L;L
PhyloP100
2.9
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
0.010
N;N
REVEL
Benign
0.049
Sift
Benign
0.49
T;T
Sift4G
Benign
0.59
T;T
Polyphen
0.095
B;B
Vest4
0.41
MutPred
0.46
Loss of catalytic residue at D206 (P = 0.0225);Loss of catalytic residue at D206 (P = 0.0225);
MVP
0.43
MPC
0.027
ClinPred
0.11
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.40
gMVP
0.59
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1010665693; hg19: chrX-15415648; COSMIC: COSV66815947; API